Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://pennyhvlp019058.livebloggs.com/45647407/semaglutide-a-potential-solution-for-metabolic-disorders